← Back to Patent Explorer
US5563292A Expired / Lapsed US ⏱️ 0.0 years remaining

Lipoxygenase inhibitors

Assignee: Merck Sharp & Dohme LLC
•
Filing: 1990-10-17
•
Granted: 1996-10-08
•
Expires: 2010-10-17
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract PCT No. PCT/US90/05824 Sec. 371 Date Apr. 2, 1992 Sec. 102(e) Date Apr. 2, 1992 PCT Filed Oct. 17, 1990Novel compounds of Formula 1 <IMAGE> (1) or a pharmaceutically acceptable salt or solvate thereof are disclosed. Also disclosed are pharmaceutical compositions containing compounds of Formula 1. Methods of treating allergy, inflammation and hyperproliferative skin diseases with compounds of Formula 1 are also disclosed.

Inventors

  • 👤 Neng-Yang Shih
  • 👤 Pietro Mangiaracina

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 21:02
CPC Classifications
C; C07; C07C; C07C259/00; C07C259/04; C07C259/06; C07C43/00; C07C43/02; C07C43/20; C07C43/23; C07C45/00; C07C45/27; C07C45/29; C07C45/292; C07C47/00; C07C47/20; C07C47/277; C07C69/00; C07C69/007; C07C69/66; C07C69/73; C07C69/734

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 125 words
A compound having the formula 3: ##STR48## wherein: R 1 and R 2 are the same and are alkyl; R 3 is alkyl; R 4 is H; W is --(CH 2 ) n X; n is 3 or 4; when n is 4, X is --OR 10 or --OC(O)R 9 ; and when n is 3, then X is --C(O)R 11 , wherein R 11 is selected from H, OH, --OCH 3 and --NHOH; R 9 is selected from H, alkyl, aryl, substituted aryl, aralkyl, cycloalkyl, or heteroaryl, with the proviso that said heteroaryl group is bound through a ring carbon; R 10 is selected from H or alkyl: and R 14 and R 15 are the same or different and are selected from alkyl.
Claim 2
Dependent Claim 125 words
A compound having the formula 3: ##STR48## wherein: R 1 and R 2 are the same and are alkyl; R 3 is alkyl; R 4 is H; W is --(CH 2 ) n X; n is 3 or 4; when n is 4, X is --OR 10 or --OC(O)R 9 ; and when n is 3, then X is --C(O)R 11 , wherein R 11 is selected from H, OH, --OCH 3 and --NHOH; R 9 is selected from H, alkyl, aryl, substituted aryl, aralkyl, cycloalkyl, or heteroaryl, with the proviso that said heteroaryl group is bound through a ring carbon; R 10 is selected from H or alkyl: and R 14 and R 15 are the same or different and are selected from alkyl.
Claim 3
Dependent Claim 10 words
The compound of claim 1 having the formula 4: ##STR49##
Claim 4
Dependent Claim 21 words
The compound of claim 2 having formula 5: ##STR50## wherein X is selected from --C(O)H, --C(O)OH, --C(O)OCH 3 , or --C(O)NHOH.
Claim 5
Dependent Claim 18 words
The compound of claim 2 having the formula 6: ##STR51## wherein X is --OH or --OC(O)CH 3 .
Claim 6
Dependent Claim 25 words
A method of treating hyperproliferative skin disease in a mammal comprising administering to said mammal an antihyperproliferative effective amount of a compound of claim 3.
Claim 7
Dependent Claim 25 words
A method of treating hyperproliferative skin disease in a mammal comprising administering to said mammal an antihyperproliferative effective amount of a compound of claim 4.
Claim 8
Dependent Claim 11 words
The compound of claim 3 having a formula selected from: ##STR52##
Claim 9
Dependent Claim 9 words
The compound of claim 3 having the formula: ##STR53##
Claim 10
Dependent Claim 11 words
The compound of claim 4 having a formula selected from: ##STR54##
Claim 11
Dependent Claim 204 words
A compound of formula 3: ##STR55## wherein: R 1 and R 2 are the same and are alkyl; R 3 is alkyl; R 4 is H; W is --(CH 2 ) n X; n is 3 or 4; when n is 4, X is --OR 10 or --OC(O)R 9 ; and when n is 3, then X is --C(O)R 11 ; R 5 is selected from H, alkyl, aryl, alkaryl, aralkyl, cycloalkyl, or heteroaryl, with the proviso that said heteroaryl group is bound through a ring carbon; R 6 and R 7 are the same or different and are selected from H, alkyl, aryl, alkaryl, aralkyl, acyl, substituted aryl, cycloalkyl or heteroaryl, with the proviso that when R 6 and/or R 7 is a heteroaryl group said heteroaryl group is bound through a ring carbon; R 9 is selected from H, alkyl, aryl, substituted aryl, aralkyl, cycloalkyl, or heteroaryl, with the proviso that said heteroaryl group is bound through a ring carbon; R 10 is selected from H or alkyl; R 11 is selected from H, --OR 5 , --NR 6 R 7 , or --NR 5 OH; and R 14 and R 15 are the same or different and are selected from alkyl.
Claim 12
Dependent Claim 204 words
A compound of formula 3: ##STR55## wherein: R 1 and R 2 are the same and are alkyl; R 3 is alkyl; R 4 is H; W is --(CH 2 ) n X; n is 3 or 4; when n is 4, X is --OR 10 or --OC(O)R 9 ; and when n is 3, then X is --C(O)R 11 ; R 5 is selected from H, alkyl, aryl, alkaryl, aralkyl, cycloalkyl, or heteroaryl, with the proviso that said heteroaryl group is bound through a ring carbon; R 6 and R 7 are the same or different and are selected from H, alkyl, aryl, alkaryl, aralkyl, acyl, substituted aryl, cycloalkyl or heteroaryl, with the proviso that when R 6 and/or R 7 is a heteroaryl group said heteroaryl group is bound through a ring carbon; R 9 is selected from H, alkyl, aryl, substituted aryl, aralkyl, cycloalkyl, or heteroaryl, with the proviso that said heteroaryl group is bound through a ring carbon; R 10 is selected from H or alkyl; R 11 is selected from H, --OR 5 , --NR 6 R 7 , or --NR 5 OH; and R 14 and R 15 are the same or different and are selected from alkyl.

References Cited (Backward Citations)

WO1981003021A1 Cited
US4708964A Cited
US4584320A Cited
WO1988003800A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1999-10-08 2000-04-08 2000-10-08 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2003-10-08 2004-04-08 2004-10-08 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2007-10-08 2008-04-08 2008-10-08 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag